Induction Chemotherapy Combined With Neoadjuvant Immunotherapy for MSS Colon Cancer
Condition: Colon Neoplasm Interventions: Drug: Oxaliplatin; Drug: Capecitabine; Drug: Anti-PD-L1 Monoclonal Antibody; Drug: Clostridium butyricum; Procedure: Colectomy Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer | Cancer & Oncology | Chemotherapy | Colectomy | Colon Cancer | Colorectal Cancer | Eloxatin | Hospitals | Immunotherapy | Neoadjuvant Chemotherapy Therapy | Neoadjuvant Therapy | Research | Xeloda